PL2768493T3 - Fitokannabinoidy do stosowania w leczeniu raka piersi - Google Patents
Fitokannabinoidy do stosowania w leczeniu raka piersiInfo
- Publication number
- PL2768493T3 PL2768493T3 PL12780523T PL12780523T PL2768493T3 PL 2768493 T3 PL2768493 T3 PL 2768493T3 PL 12780523 T PL12780523 T PL 12780523T PL 12780523 T PL12780523 T PL 12780523T PL 2768493 T3 PL2768493 T3 PL 2768493T3
- Authority
- PL
- Poland
- Prior art keywords
- phytocannabinoids
- treatment
- breast cancer
- breast
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1117956.1A GB201117956D0 (en) | 2011-10-18 | 2011-10-18 | Phytocannabinoids for use in the treatment of breast cancer |
| US201161550069P | 2011-10-21 | 2011-10-21 | |
| PCT/GB2012/052565 WO2013057487A1 (en) | 2011-10-18 | 2012-10-17 | Phytocannabinoids for use in the treatment of breast cancer |
| EP12780523.2A EP2768493B1 (en) | 2011-10-18 | 2012-10-17 | Phytocannabinoids for use in the treatment of breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2768493T3 true PL2768493T3 (pl) | 2020-03-31 |
Family
ID=45219876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12780523T PL2768493T3 (pl) | 2011-10-18 | 2012-10-17 | Fitokannabinoidy do stosowania w leczeniu raka piersi |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20140314757A1 (pl) |
| EP (1) | EP2768493B1 (pl) |
| JP (1) | JP6316193B2 (pl) |
| AR (1) | AR088391A1 (pl) |
| ES (1) | ES2751340T3 (pl) |
| GB (2) | GB201117956D0 (pl) |
| HU (1) | HUE047198T2 (pl) |
| PL (1) | PL2768493T3 (pl) |
| PT (1) | PT2768493T (pl) |
| TW (1) | TW201322978A (pl) |
| WO (1) | WO2013057487A1 (pl) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9084771B2 (en) | 2007-05-17 | 2015-07-21 | Sutter West Bay Hospitals | Methods and compositions for treating cancer |
| US10774288B2 (en) | 2013-09-18 | 2020-09-15 | The Werc Shop, LLC | Terpene-based compositions, processes, methodologies for creation and products thereby |
| EP3209312A1 (en) * | 2014-10-21 | 2017-08-30 | United Cannabis Corp. | Cannabis extracts and methods of preparing and using same |
| AU2015351937A1 (en) * | 2014-11-26 | 2017-06-29 | One World Cannabis Ltd | Synergistic use of cannabis for treating multiple myeloma |
| WO2017068349A1 (en) * | 2015-10-23 | 2017-04-27 | E-Therapeutics Plc | Cannabinoid for use in immunotherapy |
| EP3368024B1 (en) * | 2015-10-27 | 2023-09-20 | Akos Biosciences, Inc. | Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer |
| CA3006182A1 (en) | 2015-11-24 | 2017-06-01 | Constance Therapeutics, Inc. | Cannabis oil compositions and methods for preparation thereof |
| US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
| JP2019526541A (ja) | 2016-08-03 | 2019-09-19 | ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド | 大麻組成物 |
| KR20190073600A (ko) * | 2016-10-21 | 2019-06-26 | 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 | 예측 방법 및 상기 방법에 유용한 키트 |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| WO2018205038A1 (en) * | 2017-05-12 | 2018-11-15 | Tetra Bio-Pharma Inc. | Compositions comprising cannabinoids and terpenes useful in the treatment of cancer and vascular ocular disorders via inhibition of hedgehog signalling |
| EP3641754A4 (en) | 2017-06-19 | 2021-03-10 | Zelda Therapeutics Operations Pty Ltd | COMPOSITIONS AND TREATMENTS AGAINST SLEEP DISORDERS |
| EP3482751A1 (en) * | 2017-11-14 | 2019-05-15 | LDN Pharma Limited | Cancer treatment |
| WO2019144126A1 (en) * | 2018-01-22 | 2019-07-25 | Pascal Biosciences Inc. | Cannabinoids and derivatives for promoting immunogenicity of tumor and infected cells |
| EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
| CN113264914A (zh) | 2018-02-20 | 2021-08-17 | 麦姆德制药(佛罗里达)公司 | 用于治疗物质成瘾和其它障碍的遗传修饰的大麻植物和修饰的大麻素化合物 |
| WO2019222459A1 (en) * | 2018-05-18 | 2019-11-21 | Diverse Biotech, Inc. | Cannabinoid preparations and therapeutic uses |
| CA3119729A1 (en) | 2018-10-10 | 2020-04-16 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
| US20220040144A1 (en) * | 2018-12-12 | 2022-02-10 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization | Compositions and methods for the treatment of cutaneous t cell lymphoma (ctcl) |
| CA3156257A1 (en) | 2019-10-03 | 2021-04-08 | Starton Therapeutics, Inc. | TRANSDERMAL DELIVERY OF DRONABINOL |
| US12409131B2 (en) | 2019-10-03 | 2025-09-09 | Pike Therapeutics Usa, Inc. | Transdermal delivery of dronabinol |
| US12186280B2 (en) | 2019-10-11 | 2025-01-07 | Pike Therapeutics Inc. | Pharmaceutical composition and method for treating seizure disorders |
| US12016829B2 (en) | 2019-10-11 | 2024-06-25 | Pike Therapeutics Inc. | Pharmaceutical composition and method for treating seizure disorders |
| MX2022004258A (es) | 2019-10-14 | 2022-05-26 | Pike Therapeutics Inc | Entrega transdermica de cannabidiol. |
| US12268699B2 (en) | 2019-10-14 | 2025-04-08 | Pike Therapeutics Inc. | Transdermal delivery of tetrahydrocannabinol |
| US12121617B2 (en) | 2019-10-14 | 2024-10-22 | Pike Therapeutics Inc. | Transdermal delivery of cannabidiol |
| WO2022043961A1 (en) * | 2020-08-31 | 2022-03-03 | Nelson Mandela University | Cannabinoid combinations and their use in the treatment of cancer |
| IL307444A (en) * | 2021-04-05 | 2023-12-01 | The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo | Preparations and methods for the treatment of cancer |
| CN113368085A (zh) * | 2021-06-05 | 2021-09-10 | 昆明医科大学第一附属医院 | 大麻二酚在调节肿瘤微生态治疗乳腺癌药物研制中的应用 |
| CN116808176B (zh) * | 2023-08-30 | 2023-12-05 | 上海彗天锦泽生物医学科技有限公司 | 一种基于免疫检查点阻断的抗肿瘤药物组合物及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7025992B2 (en) * | 2001-02-14 | 2006-04-11 | Gw Pharma Limited | Pharmaceutical formulations |
| CA2438097C (en) * | 2001-02-14 | 2006-04-25 | Gw Pharma Limited | Cannabinoids pharmaceutical formulations |
| US6946150B2 (en) * | 2002-08-14 | 2005-09-20 | Gw Pharma Limited | Pharmaceutical formulation |
| GB2418612A (en) * | 2004-10-01 | 2006-04-05 | Gw Pharma Ltd | Inhibition of tumour cell migration with cannabinoids |
| US7968594B2 (en) * | 2005-04-27 | 2011-06-28 | Gw Pharma Limited | Pharmaceutical compositions for the treatment of pain |
| GB2448535A (en) * | 2007-04-19 | 2008-10-22 | Gw Pharma Ltd | New use for cannabinoid-containing plant extracts |
| US9084771B2 (en) | 2007-05-17 | 2015-07-21 | Sutter West Bay Hospitals | Methods and compositions for treating cancer |
| GB2471987B (en) | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| GB2460672B (en) * | 2008-06-04 | 2012-01-04 | Gw Pharma Ltd | Cannabinoids in combination with non-cannabinoid chemotherapeutic agents that are alkylating agents |
| JP2012511894A (ja) * | 2008-09-04 | 2012-05-31 | オックスフォード ビオトヘラペウトイクス エルティーディー． | Ｐｔａ０７２タンパク質 |
| GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| DK2621488T3 (en) * | 2010-09-29 | 2019-03-04 | Pulmatrix Operating Co Inc | CATIONIC DRY POWDER |
-
2011
- 2011-10-18 GB GBGB1117956.1A patent/GB201117956D0/en not_active Ceased
-
2012
- 2012-10-17 TW TW101138222A patent/TW201322978A/zh unknown
- 2012-10-17 US US14/352,390 patent/US20140314757A1/en not_active Abandoned
- 2012-10-17 PT PT127805232T patent/PT2768493T/pt unknown
- 2012-10-17 ES ES12780523T patent/ES2751340T3/es active Active
- 2012-10-17 JP JP2014536325A patent/JP6316193B2/ja active Active
- 2012-10-17 HU HUE12780523A patent/HUE047198T2/hu unknown
- 2012-10-17 WO PCT/GB2012/052565 patent/WO2013057487A1/en not_active Ceased
- 2012-10-17 EP EP12780523.2A patent/EP2768493B1/en active Active
- 2012-10-17 PL PL12780523T patent/PL2768493T3/pl unknown
- 2012-10-18 AR ARP120103899A patent/AR088391A1/es unknown
- 2012-10-18 GB GB1218732.4A patent/GB2495841B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE047198T2 (hu) | 2020-04-28 |
| EP2768493B1 (en) | 2019-07-31 |
| GB201117956D0 (en) | 2011-11-30 |
| GB2495841A (en) | 2013-04-24 |
| ES2751340T3 (es) | 2020-03-31 |
| AR088391A1 (es) | 2014-05-28 |
| GB2495841B (en) | 2016-02-10 |
| EP2768493A1 (en) | 2014-08-27 |
| GB201218732D0 (en) | 2012-12-05 |
| US20140314757A1 (en) | 2014-10-23 |
| PT2768493T (pt) | 2019-10-30 |
| GB2495841A8 (en) | 2013-05-29 |
| JP2014530247A (ja) | 2014-11-17 |
| TW201322978A (zh) | 2013-06-16 |
| JP6316193B2 (ja) | 2018-04-25 |
| WO2013057487A1 (en) | 2013-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289300A (en) | Combination therapy for treating cancer | |
| PL2768493T3 (pl) | Fitokannabinoidy do stosowania w leczeniu raka piersi | |
| IL239007B (en) | Eribulin for use in the treatment of breast cancer | |
| IL262956B (en) | Methods for increasing efficacy of folr1 cancer therapy | |
| GB201115711D0 (en) | Phyto-cannabinoids for use in the treatment of cancer | |
| HUE040524T2 (hu) | Mellrák kezelése | |
| BR112014007603A2 (pt) | métodos de tratamento do câncer | |
| LT2707030T (lt) | Vėžio gydymas | |
| HUE046667T2 (hu) | Rák kombinatív kezelése | |
| GB2516814B (en) | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer | |
| BR112014012880A2 (pt) | tratamento imunogênico do câncer | |
| IL238400A (en) | Triazulophyrazines as brd4 inhibitors for use in cancer treatment | |
| EP2751267A4 (en) | METHOD FOR THE TREATMENT OF BREAST CANCER | |
| BR112013021783A2 (pt) | sutiã para tratamento com radiação | |
| HRP20190046T1 (hr) | Kombinirana terapija za liječenje raka | |
| IL230698A0 (en) | Use of preparations containing crizotinib to treat cancer | |
| BR112013011659A2 (pt) | métodos de tratamento do câncer | |
| IL228430A0 (en) | Cancer treatment | |
| PL2742356T3 (pl) | Środki prognostyczne w leczeniu nowotworów | |
| SI2892925T1 (sl) | Kombinacijsko zdravljenje raka | |
| GB2515440B (en) | Vesicular Formulations for use in the treatment of Rosacea | |
| LT2872176T (lt) | Karboranilporfirinai, skirti naudoti vėžio gydymui | |
| HRP20180011T1 (hr) | Spojevi za uporabu u liječenju filariaza | |
| TH0901005197A (th) | การบำบัดต้านการเจริญเติบโตของเส้นโลหิตสำหรับการรักษาของโรคมะเร็งเต้านม | |
| HUP1000688A2 (en) | Use of trifluoro-phthalimides in the treatment of cancer |